P

Inventor

SHITARA KENYA

JP56 patents
⚠️ This page may combine multiple inventors who share the name “SHITARA KENYA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KYOWA HAKKO KOGYO KK

28 patents
US6437098B1Aug 20, 2002

Human chimeric antibody specific for the ganglioside GD3

KYOWA HAKKO KOGYO KK87 citations99
US5866692AFeb 2, 1999

Process for producing humanized chimera antibody

KYOWA HAKKO KOGYO KK323 citations99
US5750078AMay 12, 1998

Process for producing humanized chimera antibody

KYOWA HAKKO KOGYO KK156 citations99
US7064191B2Jun 20, 2006

Process for purifying antibody

KYOWA HAKKO KOGYO KK89 citations98
US6989145B2Jan 24, 2006

Recombinant antibody and antibody fragment

KYOWA HAKKO KOGYO KK93 citations98
US5830470ANov 3, 1998

Humanized antibodies to ganglioside GM2

KYOWA HAKKO KOGYO KK112 citations98
US6986890B1Jan 17, 2006

Anti-human VEGF receptor Flt-1 monoclonal antibody

KYOWA HAKKO KOGYO KK100 citations97
US7504104B2Mar 17, 2009

Human CDR-grafted antibody and antibody fragment thereof

KYOWA HAKKO KOGYO KK28 citations96
US6872392B2Mar 29, 2005

Humanized antibodies

KYOWA HAKKO KOGYO KK44 citations96
US6423511B1Jul 23, 2002

Humanized antibodies

KYOWA HAKKO KOGYO KK42 citations96
US5807548ASep 15, 1998

Method of treating cancer using a chimera antibody

KYOWA HAKKO KOGYO KK30 citations96
US4892935AJan 9, 1990

Anti-human pulmonary carcinoma monoclonal antibody

KYOWA HAKKO KOGYO KK47 citations93
US7498415B2Mar 3, 2009

Recombinant antibody against human insulin-like growth factor

KYOWA HAKKO KOGYO KK48 citations92
US7438911B2Oct 21, 2008

Antibody against human insulin-like growth factor

KYOWA HAKKO KOGYO KK33 citations92
US6617160B1Sep 9, 2003

Anti-human VEGF receptor Flt-1 monoclonal antibody

KYOWA HAKKO KOGYO KK24 citations92
US6042828AMar 28, 2000

Humanized antibodies to ganglioside GM2

KYOWA HAKKO KOGYO KK16 citations92
US5939532AAug 17, 1999

Humanized antibodies to ganglioside GM2

KYOWA HAKKO KOGYO KK22 citations92
US7052693B2May 30, 2006

Anti-human VEGF receptor FLT-1 monoclonal antibody

KYOWA HAKKO KOGYO KK20 citations91
US7253263B1Aug 7, 2007

Complementarity determining region-grafted antibody against ganglioside GD3 and derivative of antibody against ganglioside GD3

KYOWA HAKKO KOGYO KK37 citations90
US7404953B2Jul 29, 2008

Methods using eosinophil-specific apoptosis inducer

KYOWA HAKKO KOGYO KK6 citations74
US5874255AFeb 23, 1999

DNA encoding humanized antibodies specific for the ganglioside GM2

KYOWA HAKKO KOGYO KK9 citations74
US5552291ASep 3, 1996

Anti-human pulmonary adenocarcinoma specific monoclonal antibody

KYOWA HAKKO KOGYO KK7 citations74
US7045129B2May 16, 2006

Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3

KYOWA HAKKO KOGYO KK2 citations63
US6965024B2Nov 15, 2005

Process for producing humanized chimera antibody

KYOWA HAKKO KOGYO KK1 citations63
US6495666B2Dec 17, 2002

Polypeptide composing human chimeric antibody

KYOWA HAKKO KOGYO KK1 citations63
US5169938ADec 8, 1992

Anti-T cell receptor γ-chain monoclonal antibody

KYOWA HAKKO KOGYO KK3 citations63
US5081032AJan 14, 1992

Anti-human pulmonary adenocarcinoma monoclonal antibody

KYOWA HAKKO KOGYO KK3 citations63
US5580740ADec 3, 1996

Antihuman pulmonary adenocarcinoma monoclonal antibody

KYOWA HAKKO KOGYO KK1 citations52

KYOWA HAKKO KIRIN CO LTD

13 patents

SHITARA KENYA

6 patents

UNIV TOKAI

1 patent

NAKAMURA KAZUYASU

1 patent

MEKADA EISUKE

1 patent

Showing the top 50 of 56 patents by PatentIndex Score.